CloudC4 News

Cellebrite beats on EPS but misses on revenue; Q3 guidance signals slowing momentum in digital intelligence.

Loading exclusive…

Key Points

  • Q2 EPS of $0.11 beat consensus of $0.09.
  • Revenue missed estimates, indicating top-line weakness.
  • Q3 guidance was soft, signaling continued demand headwinds.
  • Stock dropped ~5% post-print as investors focused on revenue miss and weak outlook.

What To Watch

  • Q3 revenue guidance updates and any changes in procurement cycles.
  • Management commentary on competitive landscape and new product adoption.
  • Q4 earnings setup for potential revenue stabilization signals.